Nabil F. Saba

Saba is an elected member of the American Head and Neck Society (AHNS) and also specializes in immunotherapy for head and neck cancer, and T cell and B cell activation related to HPV-positive disease.
Saba’s work focused on translational research and the study and development of novel therapeutic agents and modalities in the head, neck, and esophageal cancer. He led several clinical trials and chaired national and investigator-initiated multi-institution studies focused on novel approaches for treating these diseases. He is also the editor of two published textbooks, ''Sinonasal and Skull Base Malignancies'' and ''Esophageal Cancer, prevention, diagnosis, and therapy''. Provided by Wikipedia